Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Cancer Reports (Hoboken, N.J.)|April 25, 2024
Senolysis of gemcitabine-induced senescent human pancreatic cancer cellsMohammad Mahbubul Hoque, Yuichi Iida, Hitoshi Kotani, et al.
Cancer Science|August 21, 2020
Immunogenic chemotherapy in two mouse colon cancer modelsTakahito Taniura, Yuichi Iida, Hitoshi Kotani, et al.
Cancer Science|August 9, 2017
Contrasting effects of cyclophosphamide on anti-CTL-associated protein 4 blockade therapy in two mouse tumor modelsYuichi Iida, Nanae Harashima, Takanobu Motoshima, et al.
Anticancer Research|July 5, 2022
Hydroxychloroquine Promotes Bcl-xL Inhibition-induced Apoptosis in BxPC-3 Human Pancreatic Cancer CellsMohammad Mahbubul Hoque, Yuichi Iida, Hitoshi Kotani, et al.
Cancer Science|May 20, 2020
Supplementation of l-arginine boosts the therapeutic efficacy of anticancer chemoimmunotherapyYusuke Satoh, Hitoshi Kotani, Yuichi Iida, et al.
Cancer Medicine|November 11, 2021
Protective role of cytoplasmic p21Cip1/Waf1 in apoptosis of CDK4/6 inhibitor-induced senescence in breast cancer cellsIrna D Kartika, Hitoshi Kotani, Yuichi Iida, et al.
Biomedical Research (Tokyo, Japan)|February 1, 2026
Tenascin-XB plays a role in the infiltration of immune cells in tumor microenvironmentAo Gong, Yuichi Iida, Kohei Kawakami, et al.
Oncotarget|June 8, 2018
Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicinTouko Inao, Yuichi Iida, Tamami Moritani, et al.
Plos One|March 8, 2018
Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cellsHiroyuki Monma, Yuichi Iida, Tamami Moritani, et al.
Pageof 3